Wilson Sonsini Goodrich & Rosati advised Anaerobe Systems on the transaction. Biolog, a leading provider of cell-based microbial and phenotypic profiling products and multiomic microbial identification...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction, and Cooley advised Accolade. Transcarent, the “One Place for Health and Care,” and Accolade, a leader...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction. Boston Scientific (NYSE: BSX) announced it has entered into a definitive agreement to acquire Bolt...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Clear Future, Inc. on the transaction, and Reinhart Boerner Van Deuren s.c. advised Veru Inc. Veru Inc. (NASDAQ: VERU), a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. is serving as legal counsel to Aadi. McDermott Will & Emery LLP is serving as legal counsel to Kaken. Cooley...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised USANA Health Sciences, while Bodman PLC acted as Hiya’s legal advisor. Fried Frank acted as counsel to BofA Securities as...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vertos Medical Inc. on the transaction. Stryker (NYSE: SYK), a global leader in medical technologies, announced a definitive agreement to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction. Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised a16z on the transaction. Talkiatry, a leading provider of high-quality, in-network psychiatric care, announced the completion of a $130 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented UpLift in the transaction. UpLift, a technology-driven behavioral health company delivering in-network therapy and psychiatry, announced that it has acquired...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
You must be a Standard 1 Year member to access this content.
